Production Centrifuge targets bioprocessing industry.
Share:
Press Release Summary:
Employing tubular bowl with working volume of 40 L, Model APD-250 is capable of generating up to 20,000 x G of separating force and processing bioreactor harvests up to 10,000 L in single shift. Large-scale production centrifuge utilizes Automatic Piston Discharge system to completely transfer separated solids from bowl without operator intervention or excessive loss of centrate.
Original Press Release:
New Production Centrifuge for the Bioprocessing Industry
FOXBORO, MA USA -- Celeros Inc. has launched their NEW Model APD-250 Centrifuge employing a tubular bowl with a working volume of 40 liters.
This NEW unit is 8 times larger than their highest capacity systems currently in use enabling the system to process bioreactor harvests of up to 10,000 liters in a single shift.
The APD-250 is a large scale production centrifuge that is capable of generating up to 20,000 x G of separating force producing the driest paste and clearest centrate of any industrial centrifuge available for the biotech industry.
The Celeros APD-250 Centrifuge utilizes a patented Automatic Piston Discharge (APD) system to completely transfer separated solids from the bowl without operator intervention or excessive loss of centrate.
"The Celeros APD series centrifuges generate the highest production yields for a centrifugation step in the industry. Until now, their use has been limited by capacity to development labs or small scale manufacturing applications." Said Wayne Nettnay, V.P. of Sales & Marketing.
"This high capacity machine extends the innovative Celeros technology into large scale manufacturing environments. This breakthrough separation system sets new standards for yield and purity and will provide tremendous economic benefits. "
For additional information visit celerosinc.com
Contact:
Celeros Inc.
Worldwide Sales
2 Annette Road, Suite 2
Foxboro, MA 02035 USA
Greg Cybulski
Phone: 508-698-3080 x109
e-mail: Greg.Cybulski@celerosinc.com
Celeros, Inc. creates business advantages for biotech and pharmaceutical organizations by delivering practical and sustainable innovations to enable significant advancements in process yield and cost control.
